Eggerthella lenta

Eggerthella lenta as Estrobolome Node#

E. lenta is a prolific beta-glucuronidase producer and a core estrobolome member alongside Bacteroides fragilis, Clostridium, and other anaerobes. Higher E. lenta abundance correlates with. Elevated urinary estrogen metabolites (indicating increased reabsorption and systemic circulation).

Higher serum estradiol in women, even when controlling for ovarian production. Enrichment in estrogen-dependent diseases: endometriosis, PCOS, breast cancer.

Iron and Molybdenum for Beta-Glucuronidase#

Beta-glucuronidase (EC 3.2.1.31) is an iron-containing metalloenzyme; some isoforms also contain molybdenum cofactors in regulatory or catalytic domains. Iron availability directly modulates E. lenta growth and beta-glucuronidase expression. Molybdenum is a cofactor for multiple oxidoreductases and may be rate-limiting for E. lenta beta-glucuronidase activity.

In endometriosis, both iron and molybdenum are often elevated (from bleeding and tissue Metal-Driven Inflammation), creating conditions favoring E. lenta expansion and maximal estrogen deconjugation.

Estrogen Feedback on Dysbiosis#

Elevated systemic estrogen (driven by E. lenta-mediated estrogen reabsorption) perpetuates dysbiosis. Estrogen is bacteriostatic to many commensals Faecalibacterium prausnitzii, Bifidobacterium. Estrogen favors estrobolome members like E. lenta.

This creates a vicious cycle: E. lenta enrichment → increased estrogen reabsorption → higher systemic estrogen → further suppression of non-estrobolome commensals → E. lenta dominance solidifies.

Dysbiosis and Intestinal Permeability in Endometriosis#

Loss of Faecalibacterium prausnitzii and Akkermansia muciniphila (suppressed by elevated estrogen) → reduced Butyrate production → loss of HDAC inhibition → downregulation of tight junction genes (claudins, ZO-1, occludin).

Increased intestinal permeability allows elevated LPS translocation. Systemic LPS activates TLR4 on macrophages and dendritic cells → IL-6, IL-8, IL-17 production → perpetuates both endometriosis lesion inflammation and gut dysbiosis.

Digoxin Metabolism#

E. lenta (and some other Gram-positive anaerobes) encodes cardiac glycoside-inactivating enzymes that metabolize digoxin and other cardiac glycosides to inactive metabolites.

This has important clinical pharmacokinetics implications: patients with high E. lenta abundance have reduced digoxin bioavailability and may require higher doses to achieve therapeutic levels.

Conversely, antibiotic treatment that reduces E. lenta can precipitate digoxin toxicity if the dose is not adjusted.

Enzyme Substrate and Metal Cofactors#

The mechanism of digoxin inactivation likely involves hydroxylation or other redox modifications. These reactions typically require metal cofactors (iron, molybdenum) and electron donors. This activity is another example of how E. lenta metabolism is sensitive to metal availability.

Iron Acquisition#

E. lenta possesses iron uptake systems and requires iron for. Beta-glucuronidase and other redox enzymes. Cytochrome c oxidases for anaerobic respiration.

Ribonucleotide reductase for nucleotide synthesis. In endometriosis, where hemoglobin from bleeding ectopic lesions provides abundant iron/heme, E. lenta proliferates.

Iron as a Selective Pressure#

High-iron conditions in endometriosis lesions select for iron-dependent pathobionts like E. lenta over commensals with lower iron demand. This again exemplifies the metals as selective pressures principle: elevated iron in endometriosis tissue selects for dysbiotic estrobolome members.

Estrobolome Community#

E. lenta operates within a broader estrobolome consortium including. Bacteroides fragilis—also produces beta-glucuronidase; can be commensal or pathobiont depending on toxigenic strain. Clostridium species (e.g., C. scindens)—deconjugate estrogen via different mechanisms; produce estrobolome-specific metabolites. Blautia and other Firmicutes—some strains produce beta-glucuronidase; context-dependent roles.

Dysbiotic Enrichment Context#

E. lenta enrichment is observed alongside Prevotella copri, Ruminococcus gnavus, and Bacteroides vulgatus in endometriosis microbiome profiles. Depleted commensals Faecalibacterium prausnitzii, Akkermansia muciniphila, Bifidobacterium that would normally compete for ecological niches or produce anti-inflammatory metabolites are reduced.

Molybdenum Cofactor (Moco)#

E. lenta, like all anaerobes with oxidoreductases, requires molybdenum cofactor (Moco) for multiple enzymes. Moco is synthesized de novo by bacteria from molybdenum (molybdenum (Mo)) and organic precursors. Molybdenum availability may be rate-limiting for E. lenta beta-glucuronidase expression, particularly in endometriosis where molybdenum elevation is part of the metallomic signature.

Competitive Displacement#

Promoting Faecalibacterium prausnitzii, Akkermansia muciniphila, and Bifidobacterium through prebiotic substrates shifts ecological balance away from E. lenta dominance, reducing beta-glucuronidase-mediated estrogen deconjugation. Restoring SCFA diversity (especially butyrate) strengthens tight junction integrity and reduces LPS-driven inflammatory signaling.

Metal Modulation#

Iron restriction: Reducing bioavailable iron removes a key growth substrate for E. lenta and other iron-dependent pathobionts.

Molybdenum as rate-limiter: Molybdenum cofactor (Moco) is required for E. lenta beta-glucuronidase expression. If molybdenum availability is rate-limiting, restricting this metal could suppress virulence enzyme activity—a hypothesis requiring further investigation.